Overall, the available evidence suggests that regulation of Ezrin gene transcription may exhibit similar characteristics in different types of tumor cells, and that Ezrin has potential as a valuable prognostic biomarker and biotherapeutic target in tumors. This evidence concerns the gene EZR and neoplasm.